PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma

BACKGROUND: PD-L1 expression levels determined by immunostaining are known to be related to the survival rate and prognosis of patients with various types of cancers, as well as to the therapeutic response to immune checkpoint inhibitors. Recently, the U.S. Food and Drug Administration approved an i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Ovarian Res
Autors principals: Kim, Ki Hyung, Choi, Kyung Un, Kim, Ahrong, Lee, So Jung, Lee, Jung Hee, Suh, Dong Soo, Kwon, Byung-su, Hwang, Chungsu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580633/
https://ncbi.nlm.nih.gov/pubmed/31208449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-019-0526-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars